• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mr 22,000钙结合蛋白(索辛)在阿霉素耐药性髓性白血病细胞系中的免疫细胞化学鉴定及定位

Immunocytochemical identification and localization of the Mr 22,000 calcium-binding protein (sorcin) in an adriamycin-resistant myelogenous leukemia cell line.

作者信息

Sugawara I, Mizumoto K, Ohkochi E, Hamada H, Tsuruo T, Mori S

机构信息

Department of Pathology, University of Tokyo.

出版信息

Jpn J Cancer Res. 1989 May;80(5):469-74. doi: 10.1111/j.1349-7006.1989.tb02338.x.

DOI:10.1111/j.1349-7006.1989.tb02338.x
PMID:2568983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5917763/
Abstract

Monoclonal antibody against the Mr 22,000 calcium-binding protein (sorcin) from an adriamycin-resistant myelogenous leukemia cell line K562 (K562/ADM) was prepared and used as a probe to study the localization of sorcin in K562/ADM cells and the parental cell line, K562. Analysis of extracts from K562/ADM cells by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorescence image analysis showed that K562/ADM cells possessed abundant sorcin in the cytoplasm which was almost entirely absent from the drug-sensitive parental cell line, K562. Furthermore, immuno-electron microscopic studies revealed that sorcin was closely associated with free ribosomes, rough endoplasmic reticulum, mitochondria, microfilament bundles and perinuclear membranes. These observations provide the first clue that the Ca-binding protein, sorcin, may play an important role in the development of the multidrug resistance phenomenon, although the relationship between sorcin and P-glycoprotein is still unknown.

摘要

制备了针对来自阿霉素耐药性髓性白血病细胞系K562(K562/ADM)的22,000分子量钙结合蛋白(索蛋白)的单克隆抗体,并将其用作探针来研究索蛋白在K562/ADM细胞和亲本细胞系K562中的定位。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和荧光图像分析对K562/ADM细胞提取物进行分析,结果显示K562/ADM细胞在细胞质中含有丰富的索蛋白,而在药物敏感的亲本细胞系K562中几乎完全不存在。此外,免疫电子显微镜研究表明,索蛋白与游离核糖体、粗面内质网、线粒体、微丝束和核周膜密切相关。这些观察结果首次提示,钙结合蛋白索蛋白可能在多药耐药现象的发生中起重要作用,尽管索蛋白与P-糖蛋白之间的关系仍然未知。

相似文献

1
Immunocytochemical identification and localization of the Mr 22,000 calcium-binding protein (sorcin) in an adriamycin-resistant myelogenous leukemia cell line.Mr 22,000钙结合蛋白(索辛)在阿霉素耐药性髓性白血病细胞系中的免疫细胞化学鉴定及定位
Jpn J Cancer Res. 1989 May;80(5):469-74. doi: 10.1111/j.1349-7006.1989.tb02338.x.
2
Detection of 300-kilodalton membrane protein in adriamycin-resistant human tumor cells by a monoclonal antibody MRK18.用单克隆抗体MRK18检测阿霉素耐药人肿瘤细胞中的300千道尔顿膜蛋白
Biochem Biophys Res Commun. 1990 Jun 15;169(2):686-91. doi: 10.1016/0006-291x(90)90385-z.
3
Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies.与多药耐药相关的22,000道尔顿钙结合蛋白(索辛)的纯化及其单克隆抗体检测
Cancer Res. 1988 Jun 1;48(11):3173-8.
4
Tegillarca granosa extract Haishengsu (HSS) suppresses expression of mdr1, BCR/ABL and sorcin in drug-resistant K562/ADM tumors in mice.厚壳贻贝提取物海生素(HSS)可抑制耐药 K562/ADM 肿瘤中 mdr1、BCR/ABL 和 sorcin 的表达。
Adv Med Sci. 2013;58(1):112-7. doi: 10.2478/v10039-012-0069-8.
5
Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca -mediated apoptosis pathways in MCF-7/ADR and K562/ADR.靶向 P-糖蛋白和 SORCIN:二氢杨梅素通过 MAPK/ERK 和 Ca 介导的凋亡通路增强阿霉素在 MCF-7/ADR 和 K562/ADR 中的抗增殖作用。
J Cell Physiol. 2018 Apr;233(4):3066-3079. doi: 10.1002/jcp.26087. Epub 2017 Nov 14.
6
Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.建立对12-O-十四烷酰佛波醇-13-乙酸酯(TPA)生长抑制作用具有抗性且表现出非P-糖蛋白介导的多药耐药性的人白血病亚系。
Int J Cancer. 1991 Jul 30;48(6):931-7. doi: 10.1002/ijc.2910480622.
7
Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.倍半萜Germacrone 通过抑制多药耐药基因 1(MDR1)/P-糖蛋白的表达逆转人慢性髓系白血病 K562/ADM 细胞的多柔比星耐药性。
Chem Biol Interact. 2018 May 25;288:32-37. doi: 10.1016/j.cbi.2018.04.012. Epub 2018 Apr 13.
8
Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.维拉帕米逆转多药耐药的机制:维拉帕米与P-糖蛋白在特定位点直接结合以及维拉帕米跨K562/ADM细胞膜向外转运。
Cancer Res. 1989 Sep 15;49(18):5002-6.
9
Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.分子量为85000的膜蛋白在耐阿霉素的人肿瘤细胞中特异性表达。
Cancer Res. 1988 Dec 15;48(24 Pt 1):7082-7.
10
FK506 reverses adriamycin resistance in a multidrug-resistant human leukemia cell line.
Kobe J Med Sci. 1992 Dec;38(6):347-63.

引用本文的文献

1
Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance.初治慢性髓性白血病患者中,对伊马替尼治疗有反应者与无反应者之间miR-142-5p的表达差异表明,其与致癌性ABL2、SRI、cKIT和MCL1信号通路存在关联,而这些信号通路对于治疗耐药性的产生至关重要。
Exp Hematol Oncol. 2020 Sep 26;9:26. doi: 10.1186/s40164-020-00183-1. eCollection 2020.
2
Sorcin a Potential Molecular Target for Cancer Therapy.索辛蛋白——癌症治疗的潜在分子靶点
Transl Oncol. 2018 Dec;11(6):1379-1389. doi: 10.1016/j.tranon.2018.08.015. Epub 2018 Sep 11.
3
Metabolic Reprogramming During Multidrug Resistance in Leukemias.白血病多药耐药过程中的代谢重编程
Front Oncol. 2018 Apr 4;8:90. doi: 10.3389/fonc.2018.00090. eCollection 2018.
4
Expression and localisation of annexin VII (synexin) isoforms in differentiating myoblasts.膜联蛋白VII(融合蛋白)亚型在成肌细胞分化过程中的表达与定位
J Muscle Res Cell Motil. 1999 Oct;20(7):669-79. doi: 10.1023/a:1005524623337.
5
Preparation and characterization of a murine monoclonal antibody (MDR3M) reactive with mdr3 gene product.一种与mdr3基因产物反应的鼠单克隆抗体(MDR3M)的制备与鉴定
Jpn J Cancer Res. 1992 Aug;83(8):795-7. doi: 10.1111/j.1349-7006.1992.tb01982.x.

本文引用的文献

1
Increased synthesis of a low molecular weight protein in vincristine-resistant cells.长春新碱耐药细胞中一种低分子量蛋白质的合成增加。
Biochem Biophys Res Commun. 1981 Mar 16;99(1):228-35. doi: 10.1016/0006-291x(81)91736-8.
2
Localization of calmodulin in rat cerebellum by immunoelectron microscopy.通过免疫电子显微镜对大鼠小脑钙调蛋白进行定位。
J Cell Biol. 1980 May;85(2):473-80. doi: 10.1083/jcb.85.2.473.
3
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.抗生物素蛋白-生物素-过氧化物酶复合物(ABC)在免疫过氧化物酶技术中的应用:ABC法与未标记抗体(PAP)法的比较。
J Histochem Cytochem. 1981 Apr;29(4):577-80. doi: 10.1177/29.4.6166661.
4
The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.注入的辣根过氧化物酶在小鼠肾近端小管吸收的早期阶段:一种新技术的超微结构细胞化学研究
J Histochem Cytochem. 1966 Apr;14(4):291-302. doi: 10.1177/14.4.291.
5
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
6
Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy.高碘酸盐-赖氨酸-多聚甲醛固定剂。一种用于免疫电子显微镜的新型固定剂。
J Histochem Cytochem. 1974 Dec;22(12):1077-83. doi: 10.1177/22.12.1077.
7
Automated analysis and survival selection of anchorage-dependent cells under normal growth conditions.正常生长条件下贴壁依赖性细胞的自动化分析与存活选择
Cytometry. 1985 Jul;6(4):368-74. doi: 10.1002/cyto.990060415.
8
Identification of a novel calcium-binding protein (CP22) in multidrug-resistant murine and hamster cells.
FEBS Lett. 1986 Jan 20;195(1-2):275-9. doi: 10.1016/0014-5793(86)80176-4.
9
Measurement of protein using bicinchoninic acid.使用二辛可宁酸测定蛋白质。
Anal Biochem. 1985 Oct;150(1):76-85. doi: 10.1016/0003-2697(85)90442-7.
10
Sorcin (V19), a soluble acidic calcium-binding protein overproduced in multidrug-resistant cells. Identification of the protein by anti-sorcin antibody.索辛(V19),一种在多药耐药细胞中过度产生的可溶性酸性钙结合蛋白。用抗索辛抗体鉴定该蛋白。
Biochem Pharmacol. 1987 Jul 15;36(14):2373-80. doi: 10.1016/0006-2952(87)90606-x.